Literature DB >> 24591888

Atrioventricular and ventricular septal defects; topographical analysis and impact of associated cardiac and extracardiac findings and postpartum outcome.

Ali Gedikbaşı1, Kazım Oztarhan2, Gökhan Yıldırım1, Ahmet Gül1, Emel Asar-Canaz1, Yavuz Ceylan1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate prognosis of types of ventricular septal defects and coexistence of associated cardiac and extracardiac defects.
METHODS: 120 prenatal diagnosed pregnancies associated with ventricular septal pathology were retrospectively evaluated and divided into four groups, as atrioventricular septal defects, perimembranous septal defects, muscular septal defects and univentricular formation. Each group was divided further into four groups, as isolated defect, co-existing extracardiac defect, septal defect with extracardiac defect and septal defect with co-existing cardiac and extracardiac defect. Postnatal follow-up was continued at least until 8 months of life.
RESULTS: Median gestational age at diagnosis was 26.3 weeks, 47 cases were diagnosed before 24 weeks. After dispersion of septal defects there was a statistical significance of p=0.0089 between groups. Of 31 cases with atrioventricular septal defects, only one case survived (3.2%) and there was a high association with extracardiac defects and abnormal karyotype (p=0.002). 69 cases with perimembranous ventricular septal defects were diagnosed, and 24 cases (34.8%) survived with significance for abnormal karyotype (p=0.039). Of 18 cases born with muscular septal defects 12 cases (66.7%) stay alive. We had two cases with univentricular structure; both cases decided for termination of pregnancy.
CONCLUSION: The more complicated and severe the pathology, the worse the prognosis. Individualized counseling is the most important point in decision making together with families.

Entities:  

Keywords:  Atrioventricular septal defects; associated abnormalities; muscular ventricular septal defects; perimembranous ventricular septal defects; prognosis

Year:  2010        PMID: 24591888      PMCID: PMC3939312     

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  18 in total

1.  Atrioventricular septal defects diagnosed in fetal life: associated cardiac and extra-cardiac abnormalities and outcome.

Authors:  I C Huggon; A C Cook; N C Smeeton; A G Magee; G K Sharland
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

2.  Atrial and ventricular septal defects - epidemiology and spontaneous closure.

Authors:  Ester Garne
Journal:  J Matern Fetal Neonatal Med       Date:  2006-05

3.  Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.

Authors:  J Hyett; M Perdu; G Sharland; R Snijders; K H Nicolaides
Journal:  BMJ       Date:  1999-01-09

Review 4.  Prenatal diagnosis of congenital heart disease.

Authors:  U Gembruch
Journal:  Prenat Diagn       Date:  1997-12       Impact factor: 3.050

5.  High prevalence of muscular ventricular septal defect in neonates.

Authors:  N Roguin; Z D Du; M Barak; N Nasser; S Hershkowitz; E Milgram
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

6.  Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus.

Authors:  L D Allan; G K Sharland; A Milburn; S M Lockhart; A M Groves; R H Anderson; A C Cook; N L Fagg
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

7.  TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts.

Authors:  Stella Marie Reamon-Buettner; Juergen Borlak
Journal:  Hum Mutat       Date:  2004-07       Impact factor: 4.878

8.  Distribution of congenital heart malformations in an autopsied child population.

Authors:  M Samánek; J Goetzová; D Benesová
Journal:  Int J Cardiol       Date:  1985-07       Impact factor: 4.164

9.  Chromosomal anomalies in fetal congenital heart disease.

Authors:  L D Allan; G K Sharland; S K Chita; S Lockhart; D J Maxwell
Journal:  Ultrasound Obstet Gynecol       Date:  1991-01-01       Impact factor: 7.299

10.  Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects.

Authors:  Mario A Cleves; Van H Savell; Sarika Raj; Weizhi Zhao; Adolfo Correa; Martha M Werler; Charlotte A Hobbs
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.